TEL AVIV, Israel--(BUSINESS WIRE)--Dec. 4, 2005--Compugen Ltd. (NASDAQ:CGEN) announced today organizational changes to support its recently disclosed development and commercialization plans for 2006 and 2007. The Company is being reorganized into three operating units: business units for Therapeutics and Diagnostic Biomarkers, and a Research and Discovery Unit.
